{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:43:15Z","timestamp":1792633395585,"version":"4.5.0"},"reference-count":45,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>An altered ambulatory blood pressure (BP) and heart rate (HR) profile is related to chronic kidney disease (CKD) and cardiorenal syndrome. In this study, we examined the effects of aliskiren, when added to angiotensin II type 1 receptor blockers, on ambulatory BP and cardiorenal function in CKD. Thirty-six hypertensive CKD patients were randomly assigned to the aliskiren add-on group (n = 18) or the benazepril add-on group (n = 18). Ambulatory BP and cardiorenal function parameters were measured at baseline and  24 weeks after treatment. Compared with the benazepril group, nighttime systolic BP variability in the aliskiren group was lower after treatment. Albuminuria was decreased in the aliskiren group, but not in the benazepril group. In addition, left ventricular mass index (LVMI) was significantly lower in the aliskiren group than in the benazepril group after treatment. In the aliskiren group, multivariate linear regression analysis showed an association between changes in albuminuria and changes in nighttime systolic BP. Furthermore, there were associations between changes in LVMI and changes in daytime HR variability, as well as between changes in LVMI and changes in plasma aldosterone concentration. These results suggest that aliskiren add-on therapy may be beneficial for suppression of renal deterioration and pathological cardiac remodeling through an improvement that is effected in ambulatory BP and HR profiles.<\/jats:p>","DOI":"10.3390\/ijms140815361","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T18:32:09Z","timestamp":1374690729000},"page":"15361-15375","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Addition of Aliskiren to Angiotensin Receptor Blocker Improves Ambulatory Blood Pressure Profile and Cardiorenal Function Better than Addition of Benazepril in Chronic Kidney Disease"],"prefix":"10.3390","volume":"14","author":[{"given":"Masato","family":"Ohsawa","sequence":"first","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Kanaoka","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Wakui","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Dejima","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Azushima","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Uneda","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Tsurumi-Ikeya","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Toya","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Fujikawa","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Umemura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"d3621","DOI":"10.1136\/bmj.d3621","article-title":"Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: Systematic review","volume":"342","author":"Hodgkinson","year":"2011","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(11)61184-7","article-title":"Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: A modelling study","volume":"378","author":"Lovibond","year":"2011","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.36.5.901","article-title":"Prognostic significance of blood pressure and heart rate variabilities: The Ohasama study","volume":"36","author":"Kikuya","year":"2000","journal-title":"Hypertension"},{"key":"ref_4","first-page":"236","article-title":"Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease","volume":"1","author":"Tamura","year":"2011","journal-title":"Am. J. Cardiovasc. Dis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archinternmed.2011.230","article-title":"Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease","volume":"171","author":"Minutolo","year":"2011","journal-title":"Arch. Intern. Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2337\/diab.42.12.1745","article-title":"Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy","volume":"42","author":"Spallone","year":"1993","journal-title":"Diabetes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/hr.2012.184","article-title":"The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease","volume":"36","author":"Yanagi","year":"2013","journal-title":"Hypertens Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/diabetes.47.9.1501","article-title":"Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects","volume":"47","author":"Nakano","year":"1998","journal-title":"Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/HJH.0b013e3282f06428","article-title":"Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: A follow-up study","volume":"25","author":"Astrup","year":"2007","journal-title":"J. Hypertens"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/HYPERTENSIONAHA.108.118398","article-title":"Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus","volume":"53","author":"Palmas","year":"2009","journal-title":"Hypertension"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1038\/ncpcardio0806","article-title":"Reduction of proteinuria with angiotensin receptor blockers","volume":"5","author":"Galle","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrneph.2009.109","article-title":"Proteinuria: Is the ONTARGET renal substudy actually off target?","volume":"5","author":"Ruggenenti","year":"2009","journal-title":"Nat. Rev. Nephrol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrneph.2009.203","article-title":"Usefulness of RAS inhibition depends on baseline albuminuria","volume":"6","author":"Ito","year":"2010","journal-title":"Nat. Rev. Nephrol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/eurheartj\/ehr017","article-title":"Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: A post hoc analysis of the combined RENAAL and IDNT trials","volume":"32","author":"Holtkamp","year":"2011","journal-title":"Eur. Heart J"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2550","article-title":"Aliskiren: The first renin inhibitor for clinical treatment","volume":"7","author":"Jensen","year":"2008","journal-title":"Nat. Rev. Drug Discov"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrneph.2009.201","article-title":"Direct renin inhibition and the kidney","volume":"6","author":"Hollenberg","year":"2010","journal-title":"Nat. Rev. Nephrol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/jhh.2009.38","article-title":"Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: Results of a randomized, double-blind study","volume":"24","author":"Palatini","year":"2010","journal-title":"J. Hum. Hypertens"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1751-7176.2012.00640.x","article-title":"Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients","volume":"14","author":"Kanaoka","year":"2012","journal-title":"J. Clin. Hypertens"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.102.13.1536","article-title":"Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study","volume":"102","author":"Sander","year":"2000","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1291\/hypres.28.1","article-title":"Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension","volume":"28","author":"Eto","year":"2005","journal-title":"Hypertens. Res"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Evans","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10641960902822518","article-title":"Identification of an increased short-term blood pressure variability on ambulatory blood pressure monitoring as a coronary risk factor in diabetic hypertensives","volume":"31","author":"Ozawa","year":"2009","journal-title":"Clin. Exp. Hypertens"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/10641960903407033","article-title":"Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial-ankle pulse wave velocity in hypertensives","volume":"31","author":"Ozawa","year":"2009","journal-title":"Clin. Exp. Hypertens"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J. Clin. Invest"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/hr.2009.131","article-title":"Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy","volume":"32","author":"Masuda","year":"2009","journal-title":"Hypertens. Res"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","article-title":"Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): A prespecified secondary analysis of a randomised controlled trial","volume":"375","author":"Bakris","year":"2010","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/hr.2009.175","article-title":"Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction","volume":"33","author":"Ito","year":"2010","journal-title":"Hypertens. Res"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/0886022X.2011.649672","article-title":"Efficacy of aliskiren in Japanese chronic kidney disease patients with hypertension","volume":"34","author":"Sakai","year":"2012","journal-title":"Ren Fail"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/HYPERTENSIONAHA.109.133884","article-title":"Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice","volume":"54","author":"Yamamoto","year":"2009","journal-title":"Hypertension"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ndt\/18.2.318","article-title":"Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis","volume":"18","author":"Fukuta","year":"2003","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2007.10.033","article-title":"Prognostic value of heart rate variability in patients with renal failure on hemodialysis","volume":"131","author":"Oikawa","year":"2009","journal-title":"Int. J. Cardiol"},{"key":"ref_34","first-page":"700","article-title":"Predictors of heart rate variability and its prognostic significance in chronic kidney disease","volume":"27","author":"Chandra","year":"2012","journal-title":"Nephrol. Dial. Transplant. Off. Public. Eur. Dial. Transplant. Assoc.-Eur. Renal Assoc"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/ndt\/gfq175","article-title":"Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment","volume":"25","author":"Siddiqi","year":"2010","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/ndt\/gfq857","article-title":"Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients","volume":"26","author":"Siddiqi","year":"2011","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1470320311414453","article-title":"Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension","volume":"12","author":"Pouleur","year":"2011","journal-title":"J. Renin. Angiotensin. Aldosterone Syst"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1161\/CIRCULATIONAHA.108.767202","article-title":"Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans","volume":"117","author":"Fisher","year":"2008","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","article-title":"Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats","volume":"52","author":"Feldman","year":"2008","journal-title":"Hypertension"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1524-6175.2005.04377.x","article-title":"Recommendations for blood pressure measurement in humans: An AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee","volume":"7","author":"Pickering","year":"2005","journal-title":"J. Clin. Hypertens"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2009.04.005","article-title":"Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis","volume":"207","author":"Mitsuhashi","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10641963.2011.583971","article-title":"Effects of Multiple Factorial Intervention on Ambulatory BP Profile and Renal Function in Hypertensive Type 2 Diabetic Patients with Overt Nephropathy\u2014A Pilot Study","volume":"33","author":"Kanaoka","year":"2011","journal-title":"Clin. Exp. Hypertens"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/10641963.2012.681082","article-title":"Relationship of ambulatory blood pressure and the heart rate profile with renal function parameters in hypertensive patients with chronic kidney disease","volume":"34","author":"Kanaoka","year":"2012","journal-title":"Clin. Exp. Hypertens"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/8\/15361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:48:11Z","timestamp":1760219291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/8\/15361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8]]}},"alternative-id":["ijms140815361"],"URL":"https:\/\/doi.org\/10.3390\/ijms140815361","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}